FierceBiotech

ACD Launches RNAscopeTM FFPE Assay Kit, a Breakthrough RNA In Situ Hybridization Product for Clinical Research and Biomarker Val

ACD Launches RNAscope TM FFPE Assay Kit, a Breakthrough RNA In Situ Hybridization Product for Clinical Research and Biomarker Validation HAYWARD, Calif., Aug. 10 /PRNewswire/ -- Advanced Cell ...
Seeking Alpha

BIO-TECHNE'S ADVANCED CELL DIAGNOSTICS (ACD) SETS NEW STANDARD IN SPATIAL BIOLOGY WITH PROTEASE-FREE RNASCOPE MULTIOMICS

Advanced Cell Diagnostics (ACD), a Bio-Techne (TECH) spatial biology brand, achieves technical breakthrough enabling protease-free, same-slide detection of protein and RNA biomarkers using ...
Nasdaq

Leica Biosystems and Bio-Techne Expand Partnership to Enable Protease-Free Workflows for Automated Spatial Multiomics on the BOND RX Research Staining Instrument

MINNEAPOLIS, April 2, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell ...
FiercePharma

Ventana Medical Systems, Inc. and Advanced Cell Diagnostics Enter Worldwide Co-Promotion Agreement for Fully Automated RNA In Si

TUCSON, Ariz., Dec. 13, 2011 /PRNewswire/ -- Ventana Medical Systems Inc. (Ventana), a member of the Roche Group, and Advanced Cell Diagnostics Inc. (ACD), announced today they have entered a ...
FierceBiotech

Bio-Techne shells out $250M for Advanced Cell Diagnostics

Bio-Techne, which makes proteins for biomedical and clinical researchers, will acquire Advanced Cell Diagnostics for $250 million in cash, with a potential $75 ...
Business Wire

NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler

NanoString and Bio-Techne Announce Offering of RNAscope Reagents Validated for Use With the GeoMx Digital Spatial Profiler Curated Menu of Off-the-Shelf RNAscope Probes Provide Seamless ...